|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
6 C! G# ~/ ]1 [4 `was to close its brain research facility in Basel, Switzerland,. s0 w7 \0 F% Z
the story noted that this move closely followed similar cuts
; {6 b( u! m: S: L, q. eby rival pharmaceutical firms. As a report from the European College
9 f2 |+ r8 e9 t( Aof Neuropsychopharmacology
5 o- c* o1 d; u. Ahad warned a few months earlier, the
! M* ^: X$ {: S* r7 M- P$ uabandonment of research into new psychiatric drugs by AstraZeneca,
) B5 x9 v4 b7 {9 {. u% PGlaxoSmithKline
8 L0 {! I7 C$ Y! n. `4 ]; X. f X9 aand others meant that “withdrawal of research
9 z2 m$ J+ Z& m8 Bresources is a withdrawal of hope for patients and their families”./ n5 }) l' z. i% [3 g: h
9 D0 Z3 n* ~3 C' ]& L9 r3 k! X# U
7 e4 Y7 c9 D; C& i回复有免费下载链接. A2 i6 w7 q: d1 p# X
$ P) Q/ ]$ I6 v
|
-
总评分: 包包 + 20
查看全部评分
|